ADPD: Proteograph Profiling of Alzheimer’s and Mild Cognitive Impairment Highlights Candidate Biomarkers

March 11th, 2021 by

John Blume, Ph.D., discusses how the Proteograph Product Suite can be used to identify novel and known candidate biomarkers in Alzheimers and Mild Cognitive Impairment (MCI) Read More